Eversept Partners LP Buys 46,724 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Eversept Partners LP boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 36.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 175,808 shares of the company’s stock after buying an additional 46,724 shares during the quarter. HCA Healthcare accounts for approximately 4.7% of Eversept Partners LP’s investment portfolio, making the stock its 5th largest position. Eversept Partners LP’s holdings in HCA Healthcare were worth $52,769,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of HCA. Congress Wealth Management LLC DE boosted its position in shares of HCA Healthcare by 3.4% in the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company’s stock worth $312,000 after buying an additional 34 shares during the period. Evergreen Private Wealth LLC raised its holdings in shares of HCA Healthcare by 0.3% during the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company’s stock worth $3,838,000 after acquiring an additional 35 shares in the last quarter. Mediolanum International Funds Ltd raised its stake in shares of HCA Healthcare by 0.3% in the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock worth $3,153,000 after acquiring an additional 36 shares during the last quarter. Prairie Wealth Advisors Inc. raised its position in HCA Healthcare by 6.1% in the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock worth $210,000 after purchasing an additional 40 shares during the last quarter. Finally, Whittier Trust Co. lifted its stake in shares of HCA Healthcare by 3.6% in the 4th quarter. Whittier Trust Co. now owns 1,195 shares of the company’s stock valued at $359,000 after purchasing an additional 41 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

HCA has been the topic of several research analyst reports. Baird R W downgraded HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 15th. Robert W. Baird reaffirmed a “neutral” rating and issued a $336.00 price objective (down from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. KeyCorp cut their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Bank of America lowered their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday, January 27th. Finally, Guggenheim began coverage on shares of HCA Healthcare in a research report on Wednesday, April 9th. They issued a “neutral” rating for the company. One analyst has rated the stock with a sell rating, seven have given a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $381.67.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $317.93 on Tuesday. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company has a market cap of $78.28 billion, a price-to-earnings ratio of 14.47, a PEG ratio of 1.10 and a beta of 1.48. The firm has a 50 day simple moving average of $328.66 and a 200 day simple moving average of $333.19.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the firm earned $5.90 EPS. Research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.91%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date was Monday, March 17th. HCA Healthcare’s payout ratio is presently 13.11%.

Insiders Place Their Bets

In related news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.